Literature DB >> 1313502

Salivary gland 99mTc-scintigraphy: a grading scale and correlation with major salivary gland flow rates.

W G Kohn1, J A Ship, J C Atkinson, L L Patton, P C Fox.   

Abstract

Sequential salivary gland scintigraphy with 99mTc-technetium pertechnetate (Tc-99) is a safe, minimally invasive test for study of major salivary glands. However, its relationship to salivary function has not been investigated in detail. We have investigated the relationship between major salivary gland flow rates and Tc-99 scans and developed a new rating scale using scans of a control group with normal salivary function. Salivary flow rates and Tc-99 scans were obtained from healthy, non-medicated subjects (n = 33) and from xerostomic patients (n = 22). There were significant differences between the groups for salivary flow rates and Tc-99 ratings. Significant correlations were found between salivary flow rates and Tc-99 ratings in the control and xerostomic groups. The Tc-99 rating scale proved reliable in assessing salivary dysfunction, and showed a high inter-examiner correlation. These results demonstrate the usefulness of salivary gland scintigraphy in assessing major salivary gland flow rates and the utility of a new rating scale.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1313502     DOI: 10.1111/j.1600-0714.1992.tb00982.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  14 in total

Review 1.  Assessment of post-radiotherapy salivary glands.

Authors:  S C H Cheng; V W C Wu; D L W Kwong; M T C Ying
Journal:  Br J Radiol       Date:  2011-05       Impact factor: 3.039

2.  Correlations between histopathologic and scintigraphic parameters of salivary glands in patients with Sjögren's syndrome.

Authors:  Tamer Aksoy; Pinar Ozgen Kiratli; Belkis Erbas
Journal:  Clin Rheumatol       Date:  2012-06-26       Impact factor: 2.980

3.  Clinical significance and diagnostic usefulness of anti-centromere antibody in Sjögren's syndrome.

Authors:  Tetsutaro Kitagawa; Koichi Shibasaki; Shuji Toya
Journal:  Clin Rheumatol       Date:  2011-06-14       Impact factor: 2.980

4.  Sicca complex among Egyptian patients with chronic hepatitis C virus infection.

Authors:  Zeinab Nawito; Amr Amin; Sohier Abu El-Fadl; Khaled Abu El Einen
Journal:  Clin Rheumatol       Date:  2011-04-13       Impact factor: 2.980

5.  Assessment of Salivary Gland Function Using Salivary Scintigraphy in Pre and Post Radioactive Iodine Therapy in Diagnosed Thyroid Carcinoma Patients.

Authors:  Raj Kumar Badam; Jyotsna Suram; Dara Balaji Gandhi Babu; Shefali Waghray; Rahul Marshal; Sharath Chandra Bontha; Reddy Lavanya; Sudheer Kanth
Journal:  J Clin Diagn Res       Date:  2016-01-01

6.  Salivary gland scintigraphy in Sjögren's syndrome and patients with sicca symptoms but without Sjögren's syndrome: the psychological profiles and predictors for salivary gland dysfunction.

Authors:  E-K Tensing; D C Nordström; S Solovieva; K-O Schauman; I Sippo-Tujunen; T Helve; S Natah; J Ma; T F Li; Y T Konttinen
Journal:  Ann Rheum Dis       Date:  2003-10       Impact factor: 19.103

Review 7.  Oral pilocarpine: a review of its pharmacological properties and clinical potential in xerostomia.

Authors:  L R Wiseman; D Faulds
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

8.  Evidence for early and persistent impairment of salivary gland excretion after irradiation of head and neck tumours.

Authors:  I H Liem; R A Olmos; A J Balm; R B Keus; H van Tinteren; R P Takes; S H Muller; A M Bruce; C A Hoefnagel; F J Hilgers
Journal:  Eur J Nucl Med       Date:  1996-11

9.  Early immunohistochemical and functional markers indicating radiation damage of the parotid gland.

Authors:  S G Hakim; H Ch Jacobsen; D Hermes; H Kosmehl; I Lauer; R Nadrowitz; P Sieg
Journal:  Clin Oral Investig       Date:  2004-01-21       Impact factor: 3.573

Review 10.  Diagnosis and treatment of xerostomia (dry mouth).

Authors:  Joel J Napeñas; Michael T Brennan; Philip C Fox
Journal:  Odontology       Date:  2009-07-29       Impact factor: 2.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.